Home
>
US Stocks
>
Keros Therapeutics Inc
Keros Therapeutics Inc
KROS

Keros Therapeutics Inc (KROS)

$40.170.52%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$40.03
Today Low/High$39.01 / $40.31
52 Week Low/High$28.5 / $88.8
Market Cap$942.38M

Company Details

Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need. Keros is a leader in understanding the role of the Transforming Growth Factor-Beta family of proteins, which are master regulators of red blood cell and platelet production as well as of the growth, repair and maintenance of muscle and bone. Keros' lead protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes and in patients with myelofibrosis. Keros' lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from iron imbalance, as well as for the treatment of fibrodysplasia ossificans progressiva. Keros' third product candidate, KER-012, is being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.
OrganisationKeros Therapeutics Inc
Employees35
IndustryCommercial Services

Discover more

Frequently Asked Questions

What is Keros Therapeutics Inc (KROS) share price today?

Can Indians buy Keros Therapeutics Inc (KROS) shares?

How can I buy Keros Therapeutics Inc (KROS) shares from India?

Can Fractional shares of Keros Therapeutics Inc (KROS) be purchased?

What are the documents required to start investing in Keros Therapeutics Inc (KROS) stocks?

We are a SEBI registered investement advisor